Literature DB >> 21977168

Cirrhosis and Chronic Viral Hepatitis as Risk Factors for Hepatocellular Carcinoma: Romanian Single-clinic Experience.

Cristin Vere Constantin1, Costin Teodor Streba, Ion Rogoveanu, Liliana Nita-Stefanescu, Alin Gabriel Ionescu.   

Abstract

INTRODUCTION: Hepatocellular carcinoma (HCC) represents the fifth most common cancer worldwide, while being the third leading cause of death by cancer. The primary risk factor for HCC seems to be liver cirrhosis. A large majority of these patients have a history of viral hepatitis.
MATERIALS AND METHODS: We selected a study lot consisting of 244 patients diagnosed with HCC, admitted between 2006 and October 2009 in the Emergency County Hospital of Craiova, Romania along with an age and gender matched control group, consisting of patients with no history of HCC or other malignancies. We interviewed all subjects regarding their alcohol consumption and background environment. All subjects underwent hepatitis B surface antigen (Hbs Ag) and anti-HCV antibodies (Anti-HCV Atb) serological determinations.
RESULTS: The study group consisted of 148 males and 96 females. Liver cirrhosis (LC) was present in 84% of the study lot, 10% associated viral B hepatitis (HBV) and 6% viral C hepatitis (HCV), with no signs of LC. We found LC to be an important risk factor for HCC (RR 6.53, CI 95% 3.18-13.38). The RR and 95% CI of HCC were 4.51 (2.48-8.21) for HbsAg positivity. We noticed a strong correlation (Chi-square test, p<0.001) between the rural environment and the association with LC. HVB was also more present in patients coming from rural areas (p< 0.01). Alcohol intake was present in 89% of the whole lot, being more correlated with the presence of LC as well as with HbsAg positivity (RR 9.165, CI 95% 4.43-18.92).
CONCLUSION: Cirrhosis proved to be the primary risk factors for HCC. We underline the fact that HCC was found to be directly associated with viral hepatitis, without evident LC. Further studies are needed in order to establish if intensified HCC screening, especially in rural areas, is required in patients with newly diagnosed viral hepatitis. The increased prevalence of HBV infections might encourage HBV vaccinations as an efficient tool to prevent HCC.

Entities:  

Keywords:  Anti-HCV Atb positivity; HbsAg positivity; Hepatocellular carcinoma; alcohol abuse; background environment; liver cirrhosis; viral hepatitis

Year:  2010        PMID: 21977168      PMCID: PMC3152834     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  29 in total

Review 1.  Prognostic prediction and treatment strategy in hepatocellular carcinoma.

Authors:  Jordi Bruix; Josep M Llovet
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

2.  Molecular pathogenesis of human hepatocellular carcinoma.

Authors:  Snorri S Thorgeirsson; Joe W Grisham
Journal:  Nat Genet       Date:  2002-08       Impact factor: 38.330

Review 3.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

Review 4.  Obesity and hepatocellular carcinoma.

Authors:  Stephen H Caldwell; Deborah M Crespo; Hyon Scott Kang; Abdullah M S Al-Osaimi
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

5.  Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study.

Authors:  A Poonawala; S P Nair; P J Thuluvath
Journal:  Hepatology       Date:  2000-10       Impact factor: 17.425

Review 6.  Hepatocellular carcinoma: epidemiology, risk factors, and screening.

Authors:  Morris Sherman
Journal:  Semin Liver Dis       Date:  2005       Impact factor: 6.115

Review 7.  Sex hormones and liver cancer.

Authors:  Nicola De Maria; Mauro Manno; Erica Villa
Journal:  Mol Cell Endocrinol       Date:  2002-07-31       Impact factor: 4.102

8.  Hepatitis B viral load predicts survival of HCC patients undergoing systemic chemotherapy.

Authors:  Winnie Yeo; Frankie K F Mo; Stephen L Chan; Nancy W Y Leung; Pun Hui; Wai-Yip Lam; Tony S K Mok; Kowk C Lam; Wing M Ho; Jane Koh; Julian W Tang; Anthony T Chan; Paul K S Chan
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

9.  Hepatocellular carcinoma in Saudi Arabia: role of hepatitis B and C infection.

Authors:  Ephraim A Ayoola; MohammeD O E H Gadour
Journal:  J Gastroenterol Hepatol       Date:  2004-06       Impact factor: 4.029

10.  A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma.

Authors:  Chung Mau Lo; Chi Leung Liu; See Ching Chan; Chi Ming Lam; Ronnie T P Poon; Irene O L Ng; Sheung Tat Fan; John Wong
Journal:  Ann Surg       Date:  2007-06       Impact factor: 12.969

View more
  5 in total

1.  Identification of ADH4 as a novel and potential prognostic marker in hepatocellular carcinoma.

Authors:  Rong-Rong Wei; Mei-Yin Zhang; Hui-Lan Rao; Heng-Ying Pu; Hui-Zhong Zhang; Hui-Yun Wang
Journal:  Med Oncol       Date:  2011-12-07       Impact factor: 3.064

2.  Relevance between HLA-DP gene rs2281388 polymorphism and hepatocellular carcinoma risk.

Authors:  Fangfeng Liu; Jianlu Wang; Hong Chang; Jun Lu; Hongguang Li
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

3.  Renal cell carcinoma risk is associated with the interactions of APOE, VHL and MTHFR gene polymorphisms.

Authors:  Cai Lv; Zhiming Bai; Zhenxiang Liu; Pengcheng Luo; Jie Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

4.  Cholesterol and Phospholipid Distribution Pattern in the Erythrocyte Membrane of Patients with Hepatitis C and Severe Fibrosis, before and after Treatment with Direct Antiviral Agents: A pilot Study.

Authors:  Charalampos Papadopoulos; Maria Panopoulou; Theodora Mylopoulou; Konstantinos Mimidis; Ioannis Tentes; Konstantinos Anagnostopoulos
Journal:  Maedica (Bucur)       Date:  2020-06

5.  Protein profiling in hepatocellular carcinoma by label-free quantitative proteomics in two west African populations.

Authors:  Haddy K S Fye; Cynthia Wright-Drakesmith; Holger B Kramer; Suzi Camey; Andre Nogueira da Costa; Adam Jeng; Alasana Bah; Gregory D Kirk; Mohamed I F Sharif; Nimzing G Ladep; Edith Okeke; Pierre Hainaut; Simon D Taylor-Robinson; Benedikt M Kessler; Maimuna E Mendy
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.